Empagliflozin is used to treat type 2 diabetes. It works in the kidneys to prevent absorption of glucose (blood sugar).
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Empagliflozin</strong> is a selective SGLT2 inhibitor synthesized via multi-step organic chemistry. Its molecular formula is C<sub>21</sub>H<sub>25</sub>NO<sub>8</sub> with CAS No. 864079-90-9.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for Type 2 diabetes management.</li>
<li>Cardiovascular risk reduction in diabetic patients.</li>
<li>Chronic kidney disease treatment protocols.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe renal impairment; requires strict moisture control and storage below 25°C to maintain stability.</p>